Real-world analysis of efficacy and safety of biweekly gemcitabine and docetaxel (GEMDOC) in heavily pretreated metastatic castration-resistant prostate cancer.

Authors: Jordan Alana Ciuro, Ahmet Yildirim, Angelo Marra, Yuan Liu, Bassel Nazha, Mehmet Asim Bilen, Jacqueline T. Brown, Bradley Curtis Carthon, Jacob E. Berchuck, Shahid Sattar Ahmed, Ravi Bharat Parikh, Omer Kucuk

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e17027

Source: Full article

---

Abstract

e17027